Does TRANYLCYPROMINE Cause Contraindicated product administered? 50 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 50 reports of Contraindicated product administered have been filed in association with TRANYLCYPROMINE (Tranylcypromine). This represents 13.0% of all adverse event reports for TRANYLCYPROMINE.
50
Reports of Contraindicated product administered with TRANYLCYPROMINE
13.0%
of all TRANYLCYPROMINE reports
2
Deaths
9
Hospitalizations
How Dangerous Is Contraindicated product administered From TRANYLCYPROMINE?
Of the 50 reports, 2 (4.0%) resulted in death, 9 (18.0%) required hospitalization, and 15 (30.0%) were considered life-threatening.
Is Contraindicated product administered Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TRANYLCYPROMINE. However, 50 reports have been filed with the FAERS database.
What Other Side Effects Does TRANYLCYPROMINE Cause?
Hypertensive crisis (53)
Drug interaction (44)
Depression (41)
Hypertension (39)
Headache (33)
Drug ineffective (30)
Insomnia (30)
Serotonin syndrome (30)
Dizziness (27)
Suicidal ideation (26)
What Other Drugs Cause Contraindicated product administered?
ABATACEPT (13,559)
METHOTREXATE (13,121)
ETANERCEPT (12,062)
TOCILIZUMAB (11,547)
ADALIMUMAB (11,270)
LEFLUNOMIDE (11,206)
HYDROXYCHLOROQUINE (10,557)
RITUXIMAB (10,479)
INFLIXIMAB (9,618)
SULFASALAZINE (8,698)
Which TRANYLCYPROMINE Alternatives Have Lower Contraindicated product administered Risk?
TRANYLCYPROMINE vs TRASTUZUMAB
TRANYLCYPROMINE vs TRASTUZUMAB-ANNS
TRANYLCYPROMINE vs TRASTUZUMAB DERUXTECAN
TRANYLCYPROMINE vs TRASTUZUMAB-DKST
TRANYLCYPROMINE vs TRASTUZUMAB-DTTB